SCHEMBL14720822

SCHEMBL14720822

CCOC(=O)c1ccc(C=C2CCN(CC(C)C)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGA O60502 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
ESR1 P03372 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
ESR2 Q92731 1/20 0.42
CA14 Q9ULX7 1/20 0.42
FDFT1 P37268 1/20 0.42
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAOA P21397 1/20 0.41
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
OPRD1 P41143 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720729 0.81 SRD5A2 (0.47) CA12CA1CA2ESR1CA7
SCHEMBL14720748 0.80 CA12 (0.44) OGACA12CA1CA2ESR1
SCHEMBL10394369 0.79 CA12 (0.51) CA12CA1CA2ESR1CA7
SCHEMBL14720551 0.77 ALDH1A1 (0.56) CA12CA1CA2ESR1CA7
SCHEMBL14720724 0.77 ALDH1A1 (0.58) CA12CA1CA2ESR1CA7
SCHEMBL4033844 0.76 ATM (0.48) LMNAALDH1A1MAPTNPC1RAB9A
SCHEMBL2387408 0.76 HPGD (0.45) LMNAALDH1A1MAPTTSHRMAPK1
SCHEMBL14721158 0.73 ALDH1A1 (0.43) OGACA12CA1CA2ESR1
SCHEMBL6705561 0.72 CA12 (0.43) CA12CA1CA2ESR1CA7
SCHEMBL14720816 0.70 MCHR1 (0.45) MAPTMCHR1NPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed